卵巢过度刺激综合征
促排卵
体外受精
排卵
人绒毛膜促性腺激素
医学
妇科
辅助生殖技术
内分泌学
怀孕
激素
生物
不育
遗传学
出处
期刊:Vitamins and hormones
日期:2018-01-01
卷期号:: 423-451
被引量:66
标识
DOI:10.1016/bs.vh.2018.01.018
摘要
The ovarian hyperstimulation syndrome (OHSS) is an iatrogenic syndrome, which may, infrequently, become severe and evenly fatal. Until the last decade, the worldwide popularity of assisted reproductive technology (ART) and ovulation induction/controlled ovarian hyperstimulation employed in ART for either in vivo fertilization or in vitro fertilization, in the last two decades, has been accompanied by an increase in the cases of OHSS. In the last decade, the substitution of the human chorionic gonadotropin trigger with the gonadotropin-releasing hormone agonist trigger has decreased the incidence of this syndrome but did not eliminate it completely. We summarize here the classification, pathophysiology, and treatment of the OHSS.
科研通智能强力驱动
Strongly Powered by AbleSci AI